Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

Garg M, Royce SG, Tikellis C, Shallue C, Batu D, Velkoska E, Burrell LM, Patel SK, Beswick L, Jackson A, Britto K, Lukies M, Sluka P, Wardan H, Hirokawa Y, Tan CW, Faux M, Burgess AW, Hosking P, Monagle S, Thomas M, Gibson PR, Lubel J.

Gut. 2019 Aug 13. pii: gutjnl-2019-318512. doi: 10.1136/gutjnl-2019-318512. [Epub ahead of print]

PMID:
31409604
2.

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.

Ji F, Yeo YH, Wei MT, Ogawa E, Enomoto M, Lee DH, Iio E, Lubel J, Wang W, Wei B, Ide T, Preda CM, Conti F, Minami T, Bielen R, Sezaki H, Barone M, Kolly P, Chu PS, Virlogeux V, Eurich D, Henry L, Bass MB, Kanai T, Dang S, Li Z, Dufour JF, Zoulim F, Andreone P, Cheung RC, Tanaka Y, Furusyo N, Toyoda H, Tamori A, Nguyen MH.

J Hepatol. 2019 Sep;71(3):473-485. doi: 10.1016/j.jhep.2019.04.017. Epub 2019 May 13.

PMID:
31096005
4.

The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status.

Garg M, Royce SG, Tikellis C, Shallue C, Sluka P, Wardan H, Hosking P, Monagle S, Thomas M, Lubel JS, Gibson PR.

Therap Adv Gastroenterol. 2019 Jan 18;12:1756284818822566. doi: 10.1177/1756284818822566. eCollection 2019.

5.

Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival.

Roberts SK, Gazzola A, Lubel J, Gow P, Bell S, Nicoll A, Dev A, Fink MA, Sood S, Knight V, Hong T, Paul E, Mishra G, Majeed A, Kemp W; Melbourne Liver Group.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1368-1375. doi: 10.1080/00365521.2018.1517277. Epub 2018 Nov 5.

PMID:
30394145
6.

Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.

Hong TP, Gow PJ, Fink M, Dev A, Roberts SK, Nicoll A, Lubel JS, Kronborg I, Arachchi N, Ryan M, Kemp WW, Knight V, Sundararajan V, Desmond P, Thompson AJ, Bell SJ.

Med J Aust. 2018 Oct 15;209(8):348-354.

PMID:
30309301
7.

Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.

Bloom S, Kemp W, Nicoll A, Roberts SK, Gow P, Dev A, Bell S, Sood S, Kronborg I, Knight V, Lewis D, Lubel J.

J Hepatol. 2018 Sep;69(3):575-583. doi: 10.1016/j.jhep.2018.04.013. Epub 2018 Apr 28.

PMID:
29709676
8.

Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease.

Garg M, Rosella O, Rosella G, Wu Y, Lubel JS, Gibson PR.

Clin Nutr. 2018 Aug;37(4):1375-1382. doi: 10.1016/j.clnu.2017.06.011. Epub 2017 Jun 15.

PMID:
28651829
9.

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study.

Lubel J, Strasser S, Stuart KA, Dore G, Thompson A, Pianko S, Bollipo S, Mitchell JL, Fragomeli V, Jones T, Chivers S, Gow P, Iser D, Levy M, Tse E, Gazzola A, Cheng W, Nazareth S, Galhenage S, Wade A, Weltman M, Wigg A, MacQuillan G, Sasadeusz J, George J, Zekry A, Roberts SK; Australian Liver Association Clinical Research Network (ALA CRN).

Antivir Ther. 2017;22(8):699-710. doi: 10.3851/IMP3168.

PMID:
28422043
10.

Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study.

Mgaieth S, Kemp W, Gow P, Fink M, Lubel J, Nicoll A, Gazzola A, Hong T, Ryan M, Knight V, Dev AT, Sood S, Bell S, Paul E, Roberts SK.

J Viral Hepat. 2017 Nov;24(11):982-989. doi: 10.1111/jvh.12717. Epub 2017 Jun 9.

PMID:
28414893
11.

Testing of direct acting antiviral agents purchased overseas: a necessary precaution to protect patients?

Lubel J, Chivers S, Taylor D, Capuano B.

Intern Med J. 2016 Sep;46(9):1111-3. doi: 10.1111/imj.13182. No abstract available.

PMID:
27633473
12.

Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study.

Doyle A, Marsh P, Gill R, Rodov M, Mohsen W, Varma P, Hong T, Strasser SI, Bell S, Ryan M, Nicoll A, Lubel J, Gow PJ, Fink MA, Roberts S, Kemp W, Kronborg I, Arachchi N, Knight V, Dev A.

Scand J Gastroenterol. 2016 Aug;51(8):979-85. doi: 10.3109/00365521.2016.1166518. Epub 2016 May 10.

PMID:
27161568
13.

Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndrome.

Philpott H, Nandurkar S, Lubel J, Gibson PR.

World J Gastroenterol. 2015 Oct 28;21(40):11379-86. doi: 10.3748/wjg.v21.i40.11379. Review.

14.

Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.

Hong TP, Gow P, Fink M, Dev A, Roberts S, Nicoll A, Lubel J, Kronborg I, Arachchi N, Ryan M, Kemp W, Knight V, Farrugia H, Thursfield V, Desmond P, Thompson AJ, Bell S.

Hepatology. 2016 Apr;63(4):1205-12. doi: 10.1002/hep.28267. Epub 2016 Feb 19.

PMID:
26435297
15.

Obscure Upper Gastrointestinal Bleeding in the Presence of Jaundice and Abdominal Pain.

Parthasarathy N, Hosking P, Lubel J.

Gastroenterology. 2015 Oct;149(4):874-5. doi: 10.1053/j.gastro.2015.06.055. Epub 2015 Aug 25. No abstract available.

PMID:
26319036
16.

Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices.

Ding NS, Nguyen T, Iser DM, Hong T, Flanagan E, Wong A, Luiz L, Tan JY, Fulforth J, Holmes J, Ryan M, Bell SJ, Desmond PV, Roberts SK, Lubel J, Kemp W, Thompson AJ.

Liver Int. 2016 Feb;36(2):240-5. doi: 10.1111/liv.12916. Epub 2015 Sep 6.

PMID:
26212020
17.

Letter: colestyramine for chronic unexplained diarrhoea - promising but much to learn?

Philpott H, Lubel J, Nandurkar S.

Aliment Pharmacol Ther. 2015 Aug;42(3):388. doi: 10.1111/apt.13274. No abstract available.

18.

Abdominal pain following drug-eluting bead transarterial chemoembolisation.

Vasudevan A, Spanger M, Lubel JS.

J Clin Exp Hepatol. 2015 Mar;5(1):105. doi: 10.1016/j.jceh.2015.01.002. Epub 2015 Jan 10. No abstract available.

19.

Abdominal Pain Following Drug-eluting Bead Transarterial Chemoembolization.

Vasudevan A, Spanger M, Lubel JS.

J Clin Exp Hepatol. 2015 Mar;5(1):93-4. doi: 10.1016/j.jceh.2015.01.001. Epub 2015 Jan 10. No abstract available.

20.

Looking beyond the scope: recurrent rectal bleeding in a young woman.

Janko N, Nguyen TC, Lubel J.

Gut. 2015 Jul;64(7):1119, 1157. doi: 10.1136/gutjnl-2014-308740. Epub 2014 Dec 30. No abstract available.

PMID:
25550181
21.

Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.

Kemp W, Levy M, Weltman M, Lubel J; Australian Liver Association (ALA).

J Gastroenterol Hepatol. 2015 Mar;30(3):453-62. doi: 10.1111/jgh.12865. Review.

PMID:
25532416
22.

Portal hypertension: pathophysiology, diagnosis and management.

Bloom S, Kemp W, Lubel J.

Intern Med J. 2015 Jan;45(1):16-26. doi: 10.1111/imj.12590. Review.

PMID:
25230084
23.

New-onset of celiac disease during interferon-based therapy for hepatitis C.

Vasudevan A, Lubel JS.

Gastroenterol Rep (Oxf). 2015 Feb;3(1):83-5. doi: 10.1093/gastro/gou060. Epub 2014 Sep 11.

24.

Natural history of chronic hepatitis B: phases in a complex relationship.

Croagh CM, Lubel JS.

World J Gastroenterol. 2014 Aug 14;20(30):10395-404. doi: 10.3748/wjg.v20.i30.10395. Review.

25.

Multiple liver lesions in a patient with positive hepatitis C serology and elevated AFP: is it HCC?

Dwyer JP, Hosking P, Lubel J.

Gastroenterology. 2014 Sep;147(3):e12-3. doi: 10.1053/j.gastro.2014.04.051. Epub 2014 Jul 23. No abstract available.

PMID:
25064545
26.

Drug-induced gastrointestinal disorders.

Philpott HL, Nandurkar S, Lubel J, Gibson PR.

Postgrad Med J. 2014 Jul;90(1065):411-9. doi: 10.1136/postgradmedj-2013-100316rep. Review.

PMID:
24942356
27.

Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study.

Garg M, Burrell LM, Velkoska E, Griggs K, Angus PW, Gibson PR, Lubel JS.

J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):559-69. doi: 10.1177/1470320314521086. Epub 2014 Feb 6.

PMID:
24505094
28.

Drug-induced gastrointestinal disorders.

Philpott HL, Nandurkar S, Lubel J, Gibson PR.

Frontline Gastroenterol. 2014 Jan;5(1):49-57. doi: 10.1136/flgastro-2013-100316. Epub 2013 Jun 19. Review.

29.

Advances in the management of hepatitis C.

Croagh CM, Lubel J.

Intern Med J. 2013 Dec;43(12):1265-71. doi: 10.1111/imj.12304. Review.

PMID:
24330361
30.

Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease.

Garg M, Rosella O, Lubel JS, Gibson PR.

Inflamm Bowel Dis. 2013 Nov;19(12):2634-43. doi: 10.1097/01.MIB.0000436957.77533.b2.

PMID:
24105392
31.

Novel association of achalasia with hereditary sensory and motor neuropathy with sensorineural deafness.

Asthana AK, Lubel JS, Kohn GP.

Dis Esophagus. 2016 Aug;29(6):691-4. doi: 10.1111/dote.12111. Epub 2013 Jul 25.

PMID:
23890250
32.

Elevated serum aminotransferases secondary to rippling muscle disease.

Nalankilli K, Lubel J.

Case Rep Gastroenterol. 2013 May 24;7(2):234-9. doi: 10.1159/000351824. Print 2013 May.

33.

Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.

Dang LJ, Lubel JS, Gunatheesan S, Hosking P, Su J.

Australas J Dermatol. 2014 Feb;55(1):75-9. doi: 10.1111/ajd.12054. Epub 2013 May 8.

PMID:
23651182
34.

Gallbladder perforation following transarterial chemoembolisation; a rare but serious complication.

Lim EJ, Spanger M, Lubel JS.

Frontline Gastroenterol. 2013 Apr;4(2):135-137. doi: 10.1136/flgastro-2012-100216. Epub 2013 Feb 21.

35.

Education and imaging: gastrointestinal: pulmonary embolism of cyanoacrylate glue following endoscopic injection of gastric varices.

Kazi S, Spanger M, Lubel J.

J Gastroenterol Hepatol. 2012 Dec;27(12):1874. No abstract available.

PMID:
23304730
36.

Unusual cause of hiccup and abdominal pain after gastric variceal obliteration.

Tang Y, Asthana A, Lubel J.

Gastroenterology. 2013 Feb;144(2):e1-2. doi: 10.1053/j.gastro.2012.08.036. Epub 2012 Dec 20. No abstract available.

PMID:
23260500
37.

Alternative investigations for irritable bowel syndrome.

Philpott H, Nandurkar S, Lubel J, Gibson PR.

J Gastroenterol Hepatol. 2013 Jan;28(1):73-7. doi: 10.1111/j.1440-1746.2012.07291.x. Review.

PMID:
23033865
38.

Review article: vitamin D and inflammatory bowel disease--established concepts and future directions.

Garg M, Lubel JS, Sparrow MP, Holt SG, Gibson PR.

Aliment Pharmacol Ther. 2012 Aug;36(4):324-44. doi: 10.1111/j.1365-2036.2012.05181.x. Epub 2012 Jun 12. Review.

39.

Education and imaging. Hepatobiliary and pancreatic: Emphysematous gastritis with hepatic portal venous gas.

Ng A, Spanger M, Lubel JS.

J Gastroenterol Hepatol. 2012 Jun;27(6):1130. doi: 10.1111/j.1440-1746.2012.07140.x. No abstract available.

PMID:
22621460
40.

Hepatitis without hepatitis?

Lim EJ, Lubel JS.

Am J Gastroenterol. 2012 May;107(5):790. doi: 10.1038/ajg.2012.16. No abstract available.

PMID:
22552245
41.

Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract.

Garg M, Angus PW, Burrell LM, Herath C, Gibson PR, Lubel JS.

Aliment Pharmacol Ther. 2012 Feb;35(4):414-28. doi: 10.1111/j.1365-2036.2011.04971.x. Epub 2012 Jan 5. Review.

42.

Spontaneous submucosal esophageal hematoma: a cause of severe thoracic back pain.

Lubel JS, Mahindra P.

Clin Gastroenterol Hepatol. 2012 Apr;10(4):A23. doi: 10.1016/j.cgh.2011.10.016. Epub 2011 Oct 28. No abstract available.

PMID:
22037430
43.

Colonic perforation during percutaneous endoscopic gastrostomy tube insertion with subsequent bumper migration into colon.

Ward M, Rees C, Asthana AK, Lubel J.

Clin Gastroenterol Hepatol. 2011 Dec;9(12):e128. doi: 10.1016/j.cgh.2011.06.020. Epub 2011 Jun 30. No abstract available.

PMID:
21723232
44.

Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.

Lubel JS, Angus PW.

J Gastroenterol Hepatol. 2010 May;25(5):864-71. doi: 10.1111/j.1440-1746.2010.06243.x. Review.

PMID:
20546439
45.

Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.

Herath CB, Lubel JS, Jia Z, Velkoska E, Casley D, Brown L, Tikellis C, Burrell LM, Angus PW.

Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G98-G106. doi: 10.1152/ajpgi.00045.2009. Epub 2009 Apr 23.

46.

Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.

Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW.

Clin Sci (Lond). 2009 Sep 14;117(11):375-86. doi: 10.1042/CS20080647.

PMID:
19371232
47.

Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research.

Lubel JS, Herath CB, Velkoska E, Casley DJ, Burrell LM, Angus PW.

Cytotechnology. 2008 Nov;58(3):119-26. doi: 10.1007/s10616-009-9185-0. Epub 2009 Feb 18.

48.

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

Lubel JS, Herath CB, Burrell LM, Angus PW.

J Gastroenterol Hepatol. 2008 Sep;23(9):1327-38. doi: 10.1111/j.1440-1746.2008.05461.x. Epub 2008 Jun 28. Review.

PMID:
18557800
49.

Time to review the selection criteria for transplantation in paracetamol-induced fulminant hepatic failure?

Gow PJ, Warrilow S, Lontos S, Lubel J, Wongseelashote S, MacQuillan GC, Jones RM, Bellomo R, Angus PW.

Liver Transpl. 2007 Dec;13(12):1762-3. No abstract available. Erratum in: Liver Transpl. 2019 Jul;25(7):1118.

50.

Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.

Lubel JS, Testro AG, Angus PW.

Intern Med J. 2007 Oct;37(10):705-12. Review.

PMID:
17894766

Supplemental Content

Support Center